Home
About Us
Products
Manus Aktteva Biopharma LLP, an ISO 9001: 2008 certified sourcing & export concern takes pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.
Category
Recommended
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Enquiry
Quick Links
Blog
Contact Us

Brimonidine Tartrate (CAS No.: 70359-46-5 (79570-19-7))

Manus Aktteva Biopharma LLP, a global supplier of Brimonidine Tartrate, 70359-46-5 (79570-19-7) offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.

CAS number:

70359-46-5 (79570-19-7)

Chemical Name:

5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate, Brimonidine Tartrate (CAS No.: 70359-46-5 (79570-19-7))

Pharmacopeia:

In House

Certificate:

GMP, Factory GMP, GMP - SFDA, cGMP, Product GMP, EUGMP, WHO GMP, ISO Certified, USFDA

Application:

For R&D Purpose

Properties
Related Intermediates

Synonym

5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate, Brimonidine Tartrate (CAS No.: 70359-46-5 (79570-19-7))

Molecular Formula

C11H10BrN5.C4H6O6

Molecular Weight

442.22

Specifications

Available on request

Packing

Export worthy packing

Material Safety Data Sheet

Available on request

Comments

REGULATORY APPROVALS : EU Compliant

Product Name	CAS No.
(+)-5-Iodo-2'-deoxyuridine	54-42-2	View \| Inquire
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	86163-17-9	View \| Inquire
(2E)-3-[1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-2-propenoic acid	74131-06-9	View \| Inquire
5-Bromo 6-Amino Quinoxaline	50538-63-9	View \| Inquire
5-Bromoquinazolin-6-ylthiourea	842138-74-3	View \| Inquire

Description:

Brimonidine acts on receptors (alpha-receptors) in the blood vessels of the eye causing them to constrict. These blood vessels control the production of the watery fluid that fills the rear of the eye. When the blood vessels constrict there is a decrease in the production of this watery fluid. Brimonidine is used in the treatment of glaucoma. This is a condition where the fluid drainage from the eye is impaired, resulting in fluid build-up and increased pressure in the eye. Brimonidine is used as an eye drop so that it can act directly where it is needed. Brimonidine may also be used to treat glaucoma that does not respond to beta-blocker eye drops.

Documentation / Approvals :

USDMF	EDMF	CEP / COS	TGA - AUSTRALIA	DMF (OPEN PART)	DMF (CLOSED PART)	TDP

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.

Are you looking for Brimonidine Tartrate (CAS No.: 70359-46-5 (79570-19-7)) with documentation like PMDA - JAPAN, DMF - CANADA, MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DMF - CTD, DCGI, ICH, COPP, TDMF, Written Confirmation? Please click here to send us sourcing request.

Why Us